Pharmaster invests in a new eye drop production line

To respond to the growth of multidose eye drops without preservatives, the Alsatian manufacturer Pharmaster of the Synerlab group has just announced the investment of 8 million euros in Erstein (Bas-Rhin), of which 500,000 euros will be covered under the plan. France revives. This recent technology is developing in a context of longer ophthalmological treatments. The new production line should be operational at the end of 2023 and should allow it to increase from 20 to 45 million units per year.

Source: https://www.lesechos.fr/pme-regions/grand-est/pharmaster-investit-dans-une-nouvelle-ligne-de-production-de-collyres-1308293